Scarica l'app Stockscreener
323.82
1.49%
4.74
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Bio Rad Laboratories Inc Borsa (BIO) Ultime notizie
Why Bio Rad Laboratories Inc. stock appeals to analystsLong Run Comfort Guide & quick comparison of popular models - ulpravda.ru
Protein engineering market is set for steady growth to reach US$ - openPR.com
What insider trading reveals about Bio Rad Laboratories Inc. stockGap Up & Safe Entry Trade Reports - ulpravda.ru
Why Bio Rad Laboratories Inc. stock is trending among retail tradersOptions Play & Daily Momentum Trading Reports - ulpravda.ru
What analyst consensus says on Bio Rad Laboratories Inc. stockJuly 2025 Final Week & Consistent Growth Equity Picks - ulpravda.ru
Is Bio Rad Laboratories Inc. stock resilient to inflationMarket Growth Report & Consistent Growth Stock Picks - ulpravda.ru
Published on: 2026-01-09 02:49:47 - ulpravda.ru
Will Bio Rad Laboratories Inc. (BUW) stock enhance shareholder valueMarket Performance Recap & Intraday High Probability Alerts - ulpravda.ru
How Bio Rad Laboratories Inc. Class B stock gains from tech spendingQuarterly Trade Report & Technical Confirmation Trade Alerts - ulpravda.ru
Published on: 2026-01-09 02:16:09 - ulpravda.ru
What margin trends mean for Bio Rad Laboratories Inc. stockWall Street Watch & AI Powered Market Trend Analysis - ulpravda.ru
Is Bio Rad Laboratories Inc. Class B stock attractive for growth fundsJuly 2025 Price Swings & Weekly High Momentum Picks - ulpravda.ru
Published on: 2026-01-08 22:32:57 - ulpravda.ru
Is Bio Rad Laboratories Inc. stock a smart buy before Fed meetingJuly 2025 Action & Free Low Drawdown Momentum Trade Ideas - ulpravda.ru
Can Bio Rad Laboratories Inc. stock sustain institutional interest2025 Price Momentum & High Accuracy Investment Signals - ulpravda.ru
Can Bio Rad Laboratories Inc. stock beat market expectations this quarter2025 Market WrapUp & Intraday High Probability Alerts - ulpravda.ru
$43.36 Bn Autism Spectrum Disorder Diagnostics Global Market Trends, Opportunities and Strategies, 2019-2024, 2025-2029F, 2034F - GlobeNewswire Inc.
Laboratory Supplies Market 2026 Forecast: In-Depth Industry - openPR.com
Basic Statistics in Laboratory Quality Control - Labroots
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 44th Annual Healthcare Conference - BioSpace
United States In-vitro Cancer Diagnostics Market 2025 | Lead - openPR.com
Is Bio Rad Laboratories Inc. Class B stock worth buying before Fed action2026 world cup usa national team round of 16 key players pressing system group prediction insights - ulpravda.ru
Earnings Risk: Can Bio Rad Laboratories Inc stock beat market expectations this quarterJuly 2025 Big Picture & Expert Approved Momentum Trade Ideas - moha.gov.vn
Bio-Rad Laboratories, Inc. $BIO Shares Acquired by Allspring Global Investments Holdings LLC - MarketBeat
Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Helicobacter Pylori Diagnostics Market Forecast Through - openPR.com
Sample Preparation Market 2025 Forecast: In-Depth Industry - openPR.com
Boston Trust Walden Corp Invests $26.76 Million in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Responsive Playbooks and the BIO Inflection - Stock Traders Daily
Marathon Asset Management Ltd Sells 7,893 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Protein A Resin Market is expected to reach US$ 4.1 billion by 2032 - openPR.com
Newborn Screening Market Assessment 2032: Segment Analysis, - openPR.com
Japan's Life Sciences Research and Clinical Applications Fuel - openPR.com
BIO (Bio-Rad Laboratories) Sale Of Property, Plant, Equipme - GuruFocus
Harbor Capital Advisors Inc. Lowers Stock Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
United states DNA Forensics Market to Reach USD 5.60 Billion - openPR.com
United states IVD Quality Control Market expected to grow at - openPR.com
United states Molecular Quality Controls Market expected - openPR.com
Bio-Rad Laboratories Earnings Notes - Trefis
Robust Growth in Molecular Quality Control Market (2025-2032): - openPR.com
Exchange Traded Concepts LLC Buys 7,648 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Life Science Instruments & Consumables Market to Reach USD - openPR.com
Enzyme-Linked Immunosorbent Assay Market is expected to reach - openPR.com
BIO (Bio-Rad Laboratories) EV-to-OCF : 16.80 (As of Dec. 23, 2025) - GuruFocus
Bio-Rad Laboratories, Inc. Class A Common Stock (NY: BIO - FinancialContent
Cell Viability Assays Market Soars as Drug Discovery Demand - openPR.com
Why Bio Rad Laboratories Inc. stock attracts global investorsTrade Risk Assessment & Capital Protection Trading Alerts - Улправда
Published on: 2025-12-20 23:30:31 - Улправда
Can Bio Rad Laboratories Inc. (BUW) stock sustain margin levelsJuly 2025 PostEarnings & Risk Managed Trade Strategies - bolumsonucanavari.com
How Bio Rad Laboratories Inc. stock performs in interest rate cycles2025 Top Decliners & Capital Efficient Trading Techniques - Улправда
Published on: 2025-12-20 08:31:22 - Улправда
Will Bio Rad Laboratories Inc. stock recover faster than marketMarket Sentiment Review & Safe Entry Point Identification - Улправда
Why Bio Rad Laboratories Inc. stock is rated strong buy2025 Biggest Moves & Weekly Return Optimization Plans - ulpravda.ru
Why Bio Rad Laboratories Inc. (BUW) stock is a must watch tickerMarket Sentiment Report & Real-Time Buy Zone Alerts - DonanımHaber
Published on: 2025-12-19 13:52:52 - DonanımHaber
Is Bio Rad Laboratories Inc. stock in correction or buying zone2025 Performance Recap & Low Drawdown Momentum Trade Ideas - DonanımHaber
Liquidity Mapping Around (BIO) Price Events - Stock Traders Daily
Loss Report: Is Bio Rad Laboratories Inc. Class B stock worth buying before Fed action - Улправда
Guidance Update: Will Bio Rad Laboratories Inc. stock gain from government policies2025 Fundamental Recap & AI Powered Buy and Sell Recommendations - Улправда
Bio-Rad Laboratories (FRA:BUWA) EV-to-FCF : 22.87 (As of Dec. 18, 2025) - GuruFocus
Assessment of InteliQ Multiqual Tube-Based QC Materials - Labroots
Bio-Rad Fails in Bid to Exclude Internal Communications in Ex-GC's Whistleblower Suit - Law.com
1.31%
0.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):